| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 416,900 | 414,900 | 425,800 | 489,800 | | Cost of Revenue | 45,000 | 50,100 | 52,300 | 49,100 | | | Gross Profit | 371,900 | 364,800 | 373,500 | 440,700 | | | Operating Expenses | | Research Development | 109,300 | 107,300 | 124,100 | 144,000 | | Selling General and Administrative | 231,400 | 228,500 | 231,300 | 261,400 | | Non Recurring | 4,900 | 26,400 | 37,500 | 169,100 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 26,300 | 2,600 | (19,400) | (133,800) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 10,700 |
-
| (1,900) | | Earnings Before Interest And Taxes | 32,100 | 13,300 | (19,400) | (135,700) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 32,100 | 13,300 | (19,400) | (135,700) | | Income Tax Expense | 2,500 | 2,900 | 12,700 | (30,300) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 29,600 | 10,400 | (32,100) | (105,400) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 29,600 | 10,400 | (32,100) | (105,400) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $29,600 | $10,400 | ($32,100) | ($105,400) |
|
0.82% Nasdaq 
Income Statement
